1. Home
  2. GKOS vs ASB Comparison

GKOS vs ASB Comparison

Compare GKOS & ASB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • ASB
  • Stock Information
  • Founded
  • GKOS 1998
  • ASB 1861
  • Country
  • GKOS United States
  • ASB United States
  • Employees
  • GKOS N/A
  • ASB N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • ASB Major Banks
  • Sector
  • GKOS Health Care
  • ASB Finance
  • Exchange
  • GKOS Nasdaq
  • ASB Nasdaq
  • Market Cap
  • GKOS 5.4B
  • ASB 4.4B
  • IPO Year
  • GKOS 2015
  • ASB N/A
  • Fundamental
  • Price
  • GKOS $84.11
  • ASB $26.49
  • Analyst Decision
  • GKOS Strong Buy
  • ASB Hold
  • Analyst Count
  • GKOS 13
  • ASB 11
  • Target Price
  • GKOS $121.46
  • ASB $27.64
  • AVG Volume (30 Days)
  • GKOS 864.7K
  • ASB 1.4M
  • Earning Date
  • GKOS 11-03-2025
  • ASB 10-23-2025
  • Dividend Yield
  • GKOS N/A
  • ASB 3.48%
  • EPS Growth
  • GKOS N/A
  • ASB N/A
  • EPS
  • GKOS N/A
  • ASB 0.78
  • Revenue
  • GKOS $432,953,000.00
  • ASB $1,035,964,000.00
  • Revenue This Year
  • GKOS $28.90
  • ASB $56.79
  • Revenue Next Year
  • GKOS $25.57
  • ASB $5.69
  • P/E Ratio
  • GKOS N/A
  • ASB $33.75
  • Revenue Growth
  • GKOS 26.70
  • ASB 3.82
  • 52 Week Low
  • GKOS $77.10
  • ASB $18.32
  • 52 Week High
  • GKOS $163.71
  • ASB $28.18
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.81
  • ASB 57.34
  • Support Level
  • GKOS $79.02
  • ASB $25.18
  • Resistance Level
  • GKOS $89.29
  • ASB $26.18
  • Average True Range (ATR)
  • GKOS 3.19
  • ASB 0.53
  • MACD
  • GKOS 0.54
  • ASB 0.01
  • Stochastic Oscillator
  • GKOS 49.76
  • ASB 74.45

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About ASB Associated Banc-Corp

Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.

Share on Social Networks: